Clinical trial
Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions
NCT00116064 · Kamuzu University of Health Sciences, Other · Completed
Key facts
| NCT number | NCT00116064 |
|---|---|
| Title | Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions |
| Official title | A Randomised Trial to Compare the Efficacy and Safety of Intranasal Lorazepam and Intramuscular Paraldehyde in the Treatment of Convulsions in Children |
| Lead sponsor | Kamuzu University of Health Sciences, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Status Epilepticus, Convulsions |
| Intervention type | Drug |
| Interventions | intranasal lorazepam, intramuscular paraldehyde |
| Enrollment | 156 |
| Start date | Jul 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Jun 27, 2005 |
| Last update posted | Jul 21, 2006 |
| Countries | Malawi |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: